Tabula Rasa HealthCare Inc (TRHC) Expected to Post Earnings of $0.07 Per Share

Wall Street analysts predict that Tabula Rasa HealthCare Inc (NASDAQ:TRHC) will announce $0.07 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Tabula Rasa HealthCare’s earnings, with estimates ranging from ($0.02) to $0.16. Tabula Rasa HealthCare posted earnings of $0.10 per share during the same quarter last year, which would suggest a negative year over year growth rate of 30%. The company is expected to announce its next earnings report on Tuesday, May 14th.

According to Zacks, analysts expect that Tabula Rasa HealthCare will report full year earnings of $0.86 per share for the current fiscal year, with EPS estimates ranging from $0.62 to $1.41. For the next financial year, analysts anticipate that the business will post earnings of $1.29 per share, with EPS estimates ranging from $0.75 to $2.09. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for Tabula Rasa HealthCare.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings data on Thursday, February 28th. The company reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $0.12 by ($0.07). The business had revenue of $57.31 million during the quarter, compared to analyst estimates of $55.70 million. Tabula Rasa HealthCare had a negative net margin of 23.14% and a positive return on equity of 7.76%.

TRHC has been the topic of a number of research reports. BidaskClub cut shares of Tabula Rasa HealthCare from a “sell” rating to a “strong sell” rating in a research note on Saturday, February 9th. Piper Jaffray Companies reiterated an “overweight” rating and issued a $80.00 price target on shares of Tabula Rasa HealthCare in a research report on Thursday, December 6th. Oppenheimer dropped their price target on shares of Tabula Rasa HealthCare from $97.00 to $88.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 6th. Benchmark began coverage on shares of Tabula Rasa HealthCare in a research report on Tuesday, January 8th. They issued a “buy” rating and a $85.00 price target on the stock. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $99.00 price target on shares of Tabula Rasa HealthCare in a research report on Thursday, February 28th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $83.48.

NASDAQ TRHC traded down $2.46 during trading hours on Monday, reaching $53.96. The company’s stock had a trading volume of 326,685 shares, compared to its average volume of 412,814. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 158.71 and a beta of 1.65. Tabula Rasa HealthCare has a fifty-two week low of $35.50 and a fifty-two week high of $91.16. The company has a current ratio of 0.84, a quick ratio of 0.79 and a debt-to-equity ratio of 0.32.

In related news, CFO Brian W. Adams sold 3,035 shares of Tabula Rasa HealthCare stock in a transaction dated Thursday, January 3rd. The stock was sold at an average price of $57.45, for a total value of $174,360.75. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction dated Thursday, January 17th. The stock was sold at an average price of $64.65, for a total value of $517,200.00. The disclosure for this sale can be found here. Insiders sold a total of 54,057 shares of company stock worth $3,175,138 in the last three months. 14.00% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently modified their holdings of TRHC. Eqis Capital Management Inc. raised its position in Tabula Rasa HealthCare by 3.2% in the 4th quarter. Eqis Capital Management Inc. now owns 6,156 shares of the company’s stock valued at $392,000 after purchasing an additional 193 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in Tabula Rasa HealthCare by 4.2% in the 4th quarter. State of Alaska Department of Revenue now owns 5,676 shares of the company’s stock worth $361,000 after purchasing an additional 231 shares in the last quarter. Comerica Bank lifted its stake in Tabula Rasa HealthCare by 1.4% in the 4th quarter. Comerica Bank now owns 16,519 shares of the company’s stock worth $934,000 after purchasing an additional 235 shares in the last quarter. D.A. Davidson & CO. lifted its stake in Tabula Rasa HealthCare by 3.8% in the 4th quarter. D.A. Davidson & CO. now owns 7,335 shares of the company’s stock worth $468,000 after purchasing an additional 270 shares in the last quarter. Finally, Legal & General Group Plc lifted its stake in Tabula Rasa HealthCare by 0.9% in the 4th quarter. Legal & General Group Plc now owns 36,450 shares of the company’s stock worth $2,305,000 after purchasing an additional 318 shares in the last quarter. 78.00% of the stock is currently owned by hedge funds and other institutional investors.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

See Also: How to Track your Portfolio in Google Finance

Get a free copy of the Zacks research report on Tabula Rasa HealthCare (TRHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.